New Pharmaceutical Technology and Engineering Institute　　

The 9th New Pharmaceutical Technology and Engineering Conference Program(Free Conference)


July 13, 2011

10：10
Openning Remarks

10：10〜11：00
Prof. Hiroaki Okada
Emeritus Professor Tokyo University of Pharmacy and Life Sciences
Current Situation on Nanotechnololgy and its Application to Drug Discovery

11：00〜11：50
Dr. Gordon T Muirhead
Vice President, Head of New Product Introduction, Global Manufacture and Supply, GlaxoSmithKline
Powder In - Tablets Out; Continuous Processing in Secondary Pharmaceutical Manufacturing

12：50〜13：40
Dr. Motoya Kohtani
Senior Analyst, Pharmaceutical & Healthcare Industry Research Group
Equity Research Dept. III, Financial & Economic Reserch Center, Nomura Securities Co., Ltd
Pharmaceutical Industry from Global Points of View

13：40〜14：30
Dr. Masanori Kobayasi
Pharmaceutical Research & Technology Laboratories, Astellas Pharma Inc.
Oral Disintegrant Tablet Formulation Composed of Functional Fine Particles
- from design to commercialization -

15：00〜15：50
Dr. Ali Afnan
President, Step Change Pharma, Inc. (Former Director of FDA)
The Drivers for Pharmaceutical Excellence

15：50〜16：40
Dr. Takayuki Ohwaki
Director of Drug Development Technology Center, Customer Joy Department, Eisai Co., Ltd.
Development of Design Space by Fluid-Bed Granulation Method

17：00〜19：00
Networking Party

Thurs. July 14, 2011

9：50〜10：40
Mr. Hiroyuki Sawai
President, Japan Generic Medicines Associate (JGA)
At Last, Japan Faces the Era of Generic Medicines

10：40〜11：30
Mr. Makoto Fukuda
Director, Pharmaceutical Technology Research & Development Laboratories, CMC Center
Takeda Pharmaceutical Company Ltd.
Development of Oral Combination Preparation and its Formulation Design

11：30〜12：20
Mr. Jerry Parker
Former Associate Director of Pharmaceutical Development, Abbott, USA
Multi-Purpose OSD Development Facilities: Design Solutions for Specific Challenges

13：10〜14：00
Dr. Johann Mueller
Managing Director, Corden Pharma GmBH (Previously AstraZeneca)
High Containment Tablet Facility - An Example

14：00〜14：50
Dr. Shigeyoshi Otani
Advisor, Research Development, Nipro Corporation (Previously Shionogi Co., Ltd.)
Scalability of High-Speed Agitating Granulation and Solubility of Tablets

15：10〜16：00
Prof. Dr. Uwe Buecheler
Senior Vice President Biopharmaceuticals Operations
Biopharmaceuticals Operations, Boehringer Ingelheim Pharma GmbH & Co. KG
Innovative and Reliable Biopharmaceutical Manufacturing Solutions

16：00〜16：50
Dr. Masahiko Kikuchi
Vice President, Vaccine Business Planning Department, Diichi Sankyo Company Ltd.
Developing Vaccine Business to Solve Public Health Problems

16：50〜17：00
Closing Remarks